Sws Partners Amgen Inc Transaction History

Sws Partners

$310 Million
Q3 2024

A detailed history of Sws Partners transactions in Amgen Inc stock. As of the latest transaction made, Sws Partners holds 820 shares of AMGN stock, worth $241,514. This represents 0.09% of its overall portfolio holdings.

Number of Shares

820

Previous 826 0.73%

Holding current value

$241,514

Previous $258,000 2.33%

% of portfolio

0.09%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $1,856 - $2,024	-6 Reduced 0.73%	820 $264,000
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $5,780 - $7,024	-22 Reduced 2.59%	826 $258,000
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $12,368 - $14,929	46 Added 5.74%	848 $241,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $8,438 - $9,519	-33 Reduced 3.95%	802 $230,000
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $182,572 - $226,669	835 New	835 $224,000
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $176,493 - $196,406	-765 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $1.3 Million - $1.44 Million	-5,920 Reduced 88.56%	765 $185,000
Q3 2019 Nov 15, 2019	BUY	$174.11 - $208.62 $1.16 Million - $1.39 Million	6,685 New	6,685 $1.23 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $70,737 - $79,453	-426 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $508 - $594	3 Added 0.71%	426 $71,000
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $71,398 - $79,773	423	423 $74,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

News

Stay updated on Sws Partners with notifications on news.

Account